170 related articles for article (PubMed ID: 36326386)
1. The reliability and validity of the Turkish version of the multiple sclerosis impact scale-29.
Özden F; Özkeskin M; Yüceyar N
Turk J Med Sci; 2022 Aug; 52(4):1216-1222. PubMed ID: 36326386
[TBL] [Abstract][Full Text] [Related]
2. Validity and reliability of the Finnish version of the Multiple Sclerosis Impact Scale-29.
Rosti-Otajärvi E; Hämäläinen P; Wiksten A; Hakkarainen T; Ruutiainen J
Brain Behav; 2017 Jul; 7(7):e00725. PubMed ID: 28729932
[TBL] [Abstract][Full Text] [Related]
3. The reliability and validity of the Turkish version of the Multiple Sclerosis Questionnaire for physiotherapists.
Büyükaşık M; Özkeskin M; Özden F
Disabil Rehabil; 2022 Jun; 44(12):2908-2914. PubMed ID: 33226865
[TBL] [Abstract][Full Text] [Related]
4. Psychometric properties of the EuroQol Five Dimensional Questionnaire (EQ-5D-3L) in caregivers of autistic children.
Khanna R; Jariwala K; Bentley JP
Qual Life Res; 2013 Dec; 22(10):2909-20. PubMed ID: 23615959
[TBL] [Abstract][Full Text] [Related]
5. Construct validity and reliability of EQ-5D-3L for stroke survivors in a lower middle income setting.
Mahesh PKB; Gunathunga MW; Jayasinghe S; Arnold SM; Senanayake S; Senanayake C; De Silva LSD; Kularatna S
Ceylon Med J; 2019 Jun; 64(2):52-58. PubMed ID: 31455067
[TBL] [Abstract][Full Text] [Related]
6. The comparison of fatigue, sleep quality, physical activity, quality of life, and psychological status in multiple sclerosis patients with or without COVID-19.
Özkeskin M; Özden F; Karaman B; Ekmekçi Ö; Yüceyar N
Mult Scler Relat Disord; 2021 Oct; 55():103180. PubMed ID: 34352513
[TBL] [Abstract][Full Text] [Related]
7. Validity and reliability of EQ-5D-3L for breast cancer patients in Korea.
Kim SH; Jo MW; Lee JW; Lee HJ; Kim JK
Health Qual Life Outcomes; 2015 Dec; 13():203. PubMed ID: 26694964
[TBL] [Abstract][Full Text] [Related]
8. Cross-cultural adaptation, reliability, and validity of the Turkish version of the SymptoMScreen.
Özkeskin M; Özden F; Bakırhan S; Yüceyar N
Mult Scler Relat Disord; 2021 May; 50():102803. PubMed ID: 33561665
[TBL] [Abstract][Full Text] [Related]
9. [Validation of selected aspects of psychometry of the Polish version of the Multiple Sclerosis Impact Scale 29 (MSIS-29)].
Jamroz-Wiśniewska A; Papuć E; Bartosik-Psujek H; Belniak E; Mitosek-Szewczyk K; Stelmasiak Z
Neurol Neurochir Pol; 2007; 41(3):215-22. PubMed ID: 17629814
[TBL] [Abstract][Full Text] [Related]
10. Validation analysis of the Polish version of the Multiple Sclerosis International Quality of Life Questionnaire (MusiQoL).
Jamroz-Wiśniewska A; Stelmasiak Z; Bartosik-Psujek H
Neurol Neurochir Pol; 2011; 45(3):235-44. PubMed ID: 21866480
[TBL] [Abstract][Full Text] [Related]
11. The reliability and validity of the Turkish version of the apraxia screen of TULIA in multiple sclerosis patients.
Yıldız Z; Doymaz F; Özden F
Disabil Rehabil; 2022 Dec; 44(25):8042-8047. PubMed ID: 34898347
[TBL] [Abstract][Full Text] [Related]
12. Tried and tested: the psychometric properties of the multiple sclerosis impact scale (MSIS-29) in a population-based study.
Gray O; McDonnell G; Hawkins S
Mult Scler; 2009 Jan; 15(1):75-80. PubMed ID: 18829636
[TBL] [Abstract][Full Text] [Related]
13. Psychometric properties of the Croatian version of the depression, anxiety, and stress scale-21 and multiple sclerosis impact scale-29 in multiple sclerosis patients.
Rogić Vidaković M; Šimić N; Poljičanin A; Nikolić Ivanišević M; Ana J; Đogaš Z
Mult Scler Relat Disord; 2021 May; 50():102850. PubMed ID: 33636617
[TBL] [Abstract][Full Text] [Related]
14. Systemic Sclerosis Quality of Life Questionnaire (SScQoL): translation into Turkish and assessing its psychometric properties.
Sarac DC; Bayraktar D; Tore NG; Kurut Aysin I; Otman E; Inanc I; Demirbas S; Coskun B; Erol K; Ustun O; Akatay EA; Oskay D; Gucenmez S; Ozmen M; Akar S
Clin Rheumatol; 2023 Aug; 42(8):2135-2143. PubMed ID: 37178266
[TBL] [Abstract][Full Text] [Related]
15. The EQ-5D-5L Is Superior to the -3L Version in Measuring Health-related Quality of Life in Patients Awaiting THA or TKA.
Jin X; Al Sayah F; Ohinmaa A; Marshall DA; Smith C; Johnson JA
Clin Orthop Relat Res; 2019 Jul; 477(7):1632-1644. PubMed ID: 30801280
[TBL] [Abstract][Full Text] [Related]
16. Validation and reliability of the Chichewa translation of the EQ-5D quality of life questionnaire in adults with orthopaedic injuries in Malawi.
Chokotho L; Mkandawire N; Conway D; Wu HH; Shearer DD; Hallan G; Gjertsen JE; Young S; Lau BC
Malawi Med J; 2017 Jun; 29(2):84-88. PubMed ID: 28955412
[TBL] [Abstract][Full Text] [Related]
17. Cross-Cultural Adaptation and Validation of the Hindi Version of EuroQol (EQ-5D-3L) Health Questionnaire in Patients With Chronic Low Back Pain.
Goyal A; Makkar JK; Ghai B; Sharma R; Kumar V
Spine (Phila Pa 1976); 2023 Oct; 48(19):E330-E338. PubMed ID: 36191070
[TBL] [Abstract][Full Text] [Related]
18. The External Validity of Mapping MSIS-29 on EQ-5D Among Individuals With Multiple Sclerosis in Sweden.
Ernstsson O; Tinghög P; Alexanderson K; Hillert J; Burström K
MDM Policy Pract; 2017; 2(1):2381468317692806. PubMed ID: 30288416
[No Abstract] [Full Text] [Related]
19. The multiple sclerosis impact scale (MSIS-29) is a reliable and sensitive measure.
McGuigan C; Hutchinson M
J Neurol Neurosurg Psychiatry; 2004 Feb; 75(2):266-9. PubMed ID: 14742602
[TBL] [Abstract][Full Text] [Related]
20. The reliability and validity of the Turkish version of the Telemedicine Satisfaction and Usefulness Questionnaire (TSUQ) and Telemedicine Patient Questionnaire (TPQ) in individuals with multiple sclerosis.
Özkeskin M; Özden F; Ekmekçi Ö; Yüceyar N
Neurol Sci; 2022 Mar; 43(3):1921-1927. PubMed ID: 34342782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
